Deerfield Management’s Spark Therapeutics ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-283,000
Closed -$15.1M – 105
2017
Q1
$15.1M Hold
283,000
– – 0.58% 55
2016
Q4
$14.1M Sell
283,000
-85,000
-23% -$4.55M 0.58% 53
2016
Q3
$22.1M Hold
368,000
– – 1.03% 33
2016
Q2
$18.8M Buy
+368,000
New +$15.7M 0.74% 45
2015
Q3
– Sell
-631,192
Closed -$38M – 147
2015
Q2
$38M Hold
631,192
– – 1.27% 24
2015
Q1
$48.9M Buy
+631,192
New +$36.4M 1.58% 16

Other funds holding ONCE

Deerfield Management's ONCE Position: Q2 2017 in Review

Deerfield Management sold out of Spark Therapeutics (ONCE) in Q2 2017, closing a stake of 283,000 shares — an estimated $15.1M sold.

Deerfield Management first reported a position in ONCE in Q1 2015 and held it in 6 quarters. The position peaked at $48.9M in Q1 2015. 127 funds tracked by Wall St. Rank hold ONCE as of Q2 2017.

  • Deerfield Management reported no remaining Spark Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Deerfield Management sold 283,000 Spark Therapeutics shares in Q2 2017, an estimated $15.1M.
  • Deerfield Management first reported a position in Spark Therapeutics in Q1 2015 and held it in 6 quarters.
  • Deerfield Management's Spark Therapeutics position peaked at $48.9M in Q1 2015.
  • 127 funds tracked by Wall St. Rank held Spark Therapeutics as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.